OPTN OptiNose, Inc.

OptiNose Inc is a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists.

$1.94  +0.06 (3.19%)
As of 05/26/2022 16:30:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  10/13/2017
Outstanding shares:  82,681,048
Average volume:  126,665
Market cap:   $155,440,370
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYZ2JT0
Valuation   (See tab for details)
PE ratio:   -1.97
PB ratio:   15.16
PS ratio:   2.01
Return on equity:   181.85%
Net income %:   -105.32%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy